glp 1 receptor agonists weight loss GLP-1 For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Glucagon-like peptide-1 receptor agonists (GLP-1RAs)
Description
Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 6575 years
Ten-year follow-up in sleep AHEAD
The glucagon receptor component appears to drive much of this effect
Sometimes the answer is simpler than a full receptor reset
SUSTAIN-6 evaluated once-weekly semaglutide versus placebo in patients at moderate and high cardiovascular risk with type 2 diabetes, showing a 26% relative risk reduction in MACE (HR 0.74, 95% CI 0.58 to 0.95)
Dungan, K
